Post-earnings recap
Reported
Fri, Nov 4, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported better-than-expected earnings per share, which led to a positive stock reaction, with shares rising by 5.88%. The significant EPS surprise indicates strong performance relative to expectations, although no revenue figures were disclosed. Investors may view this earnings beat as a positive sign for the company's financial health.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.21 | N/A | +252.17% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.